Division of Gastroenterology and Hepatology, Michigan Medicine, Ann Arbor, Michigan.
In2Being LLC, Saline, Michigan.
Clin Gastroenterol Hepatol. 2023 Mar;21(3):832-834. doi: 10.1016/j.cgh.2021.11.034. Epub 2021 Dec 2.
Functional constipation (FC) is one of the most frequently encountered gastrointestinal conditions in practice. Practice guidelines universally recommend that patients with typical constipation symptoms and no alarm features be treated empirically with dietary/lifestyle interventions and laxative therapy. Unfortunately, by the time a patient reaches a gastroenterologist, these treatments frequently have already been tried. Anorectal function testing (anorectal manometry [ARM] and balloon expulsion test [BET]) is the next best step in management guidelines in this all-too-common scenario, because treatment can then be targeted toward pelvic floor dysfunction or colon transit abnormalities. Unfortunately, more than 95% of patients continue to take only over-the-counter laxatives and receive empirical dietary advice, whereas fewer than 2% undergo physiologic evaluation to ascertain the cause of their symptoms. Indeed, more than 90% of patients desire more effective treatment options. These observations call into question the wisdom of a management strategy that fails to recognize the intrinsic diversity of the constipation universe and reinforces the misguided "one size fits all" empirical treatment strategy.
功能性便秘(FC)是临床上最常见的胃肠道疾病之一。实践指南普遍建议对有典型便秘症状且无报警特征的患者进行经验性治疗,包括饮食/生活方式干预和泻药治疗。不幸的是,当患者就诊于胃肠病学家时,这些治疗通常已经尝试过了。肛肠功能检测(肛肠测压法[ARM]和球囊排出试验[BET])是这种常见情况下管理指南中的下一步最佳步骤,因为可以针对盆底功能障碍或结肠转运异常进行治疗。不幸的是,超过 95%的患者继续只服用非处方泻药并接受经验性饮食建议,而接受生理评估以确定症状原因的患者不到 2%。事实上,超过 90%的患者希望获得更有效的治疗选择。这些观察结果对未能认识到便秘宇宙内在多样性的管理策略的合理性提出了质疑,并强化了误导性的“一刀切”经验治疗策略。